Efficacy of nivolumab monotherapy against acral lentiginous melanoma and mucosal melanoma in Asian patients

Br J Dermatol. 2019 May;180(5):1230-1231. doi: 10.1111/bjd.17434. Epub 2019 Jan 16.

Authors

T Maeda¹, K Yoshino¹, K Nagai¹, S Oaku¹, M Kato¹, A Hiura¹, H Hata²

Affiliations

¹ Department of Dermatologic Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
² Department of Dermatology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.

PMID: 30447078
DOI: 10.1111/bjd.17434

No abstract available

Publication types

Letter

MeSH terms

Antineoplastic Agents, Immunological / therapeutic use*
Asian People
DNA Mutational Analysis
Female
Humans
Japan / epidemiology
Kaplan-Meier Estimate
Melanoma / drug therapy*
Melanoma / genetics
Melanoma / mortality
Melanoma / secondary
Mutation
Nivolumab / therapeutic use*
Progression-Free Survival
Proto-Oncogene Proteins B-raf / genetics
Retrospective Studies
Skin Neoplasms / drug therapy*
Skin Neoplasms / genetics
Skin Neoplasms / mortality
Skin Neoplasms / pathology

Substances

Antineoplastic Agents, Immunological
Nivolumab
BRAF protein, human
Proto-Oncogene Proteins B-raf